2.4.0.8 Html 336 470 1 true 81 0 false 10 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://raptorpharma.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 010000 - Statement - Consolidated Balance Sheets Sheet http://raptorpharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 010100 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://raptorpharma.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 020000 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://raptorpharma.com/role/ConsolidatedStatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss false false R5.htm 030000 - Statement - Consolidated Statement of Stockholders' Equity (Deficit) Sheet http://raptorpharma.com/role/ConsolidatedStatementOfStockholdersEquityDeficit Consolidated Statement of Stockholders' Equity (Deficit) false false R6.htm 030100 - Statement - Consolidated Statement of Stockholders' Equity (Deficit) (Parenthetical) Sheet http://raptorpharma.com/role/ConsolidatedStatementOfStockholdersEquityDeficitParenthetical Consolidated Statement of Stockholders' Equity (Deficit) (Parenthetical) false false R7.htm 040000 - Statement - Consolidated Statements of Cash Flows Sheet http://raptorpharma.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R8.htm 060100 - Disclosure - NATURE OF OPERATIONS AND BUSINESS RISKS Sheet http://raptorpharma.com/role/NatureOfOperationsAndBusinessRisks NATURE OF OPERATIONS AND BUSINESS RISKS false false R9.htm 060200 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R10.htm 060300 - Disclosure - INTANGIBLE ASSETS AND GOODWILL Sheet http://raptorpharma.com/role/IntangibleAssetsAndGoodwill INTANGIBLE ASSETS AND GOODWILL false false R11.htm 060400 - Disclosure - FIXED ASSETS Sheet http://raptorpharma.com/role/FixedAssets FIXED ASSETS false false R12.htm 060500 - Disclosure - FAIR VALUE MEASUREMENT Sheet http://raptorpharma.com/role/FairValueMeasurement FAIR VALUE MEASUREMENT false false R13.htm 060600 - Disclosure - NOTE PAYABLE Sheet http://raptorpharma.com/role/NotePayable NOTE PAYABLE false false R14.htm 060700 - Disclosure - ACCRUED LIABILITIES Sheet http://raptorpharma.com/role/AccruedLiabilities ACCRUED LIABILITIES false false R15.htm 060800 - Disclosure - STOCK OPTION PLANS Sheet http://raptorpharma.com/role/StockOptionPlans STOCK OPTION PLANS false false R16.htm 060900 - Disclosure - INCOME TAXES Sheet http://raptorpharma.com/role/IncomeTaxes INCOME TAXES false false R17.htm 061000 - Disclosure - ISSUANCE OF COMMON STOCK Sheet http://raptorpharma.com/role/IssuanceOfCommonStock ISSUANCE OF COMMON STOCK false false R18.htm 061100 - Disclosure - WARRANTS Sheet http://raptorpharma.com/role/Warrants WARRANTS false false R19.htm 061200 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://raptorpharma.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R20.htm 061300 - Disclosure - QUALIFYING THERAPEUTIC DISCOVERY PROJECT GRANT Sheet http://raptorpharma.com/role/QualifyingTherapeuticDiscoveryProjectGrant QUALIFYING THERAPEUTIC DISCOVERY PROJECT GRANT false false R21.htm 061400 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://raptorpharma.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R22.htm 061500 - Disclosure - QUARTERLY RESULTS OF OPERATIONS (UNAUDITED) Sheet http://raptorpharma.com/role/QuarterlyResultsOfOperationsUnaudited QUARTERLY RESULTS OF OPERATIONS (UNAUDITED) false false R23.htm 061600 - Disclosure - Schedule II VALUATION AND QUALIFYING ACCOUNTS Sheet http://raptorpharma.com/role/ScheduleIiValuationAndQualifyingAccounts Schedule II VALUATION AND QUALIFYING ACCOUNTS false false R24.htm 070200 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R25.htm 080200 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R26.htm 080300 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables) Sheet http://raptorpharma.com/role/IntangibleAssetsAndGoodwillTables INTANGIBLE ASSETS AND GOODWILL (Tables) false false R27.htm 080400 - Disclosure - FIXED ASSETS (Tables) Sheet http://raptorpharma.com/role/FixedAssetsTables FIXED ASSETS (Tables) false false R28.htm 080500 - Disclosure - FAIR VALUE MEASUREMENT (Tables) Sheet http://raptorpharma.com/role/FairValueMeasurementTables FAIR VALUE MEASUREMENT (Tables) false false R29.htm 080700 - Disclosure - ACCRUED LIABILITIES (Tables) Sheet http://raptorpharma.com/role/AccruedLiabilitiesTables ACCRUED LIABILITIES (Tables) false false R30.htm 080800 - Disclosure - STOCK OPTION PLANS (Tables) Sheet http://raptorpharma.com/role/StockOptionPlansTables STOCK OPTION PLANS (Tables) false false R31.htm 080900 - Disclosure - INCOME TAXES (Tables) Sheet http://raptorpharma.com/role/IncomeTaxesTables INCOME TAXES (Tables) false false R32.htm 081000 - Disclosure - ISSUANCE OF COMMON STOCK (Tables) Sheet http://raptorpharma.com/role/IssuanceOfCommonStockTables ISSUANCE OF COMMON STOCK (Tables) false false R33.htm 081100 - Disclosure - WARRANTS (Tables) Sheet http://raptorpharma.com/role/WarrantsTables WARRANTS (Tables) false false R34.htm 081200 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://raptorpharma.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) false false R35.htm 081500 - Disclosure - QUARTERLY RESULTS OF OPERATIONS (UNAUDITED) (Tables) Sheet http://raptorpharma.com/role/QuarterlyResultsOfOperationsUnauditedTables QUARTERLY RESULTS OF OPERATIONS (UNAUDITED) (Tables) false false R36.htm 090100 - Disclosure - NATURE OF OPERATIONS AND BUSINESS RISKS (Details) Sheet http://raptorpharma.com/role/NatureOfOperationsAndBusinessRisksDetails NATURE OF OPERATIONS AND BUSINESS RISKS (Details) false false R37.htm 090200 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://raptorpharma.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) false false R38.htm 090300 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details) Sheet http://raptorpharma.com/role/IntangibleAssetsAndGoodwillDetails INTANGIBLE ASSETS AND GOODWILL (Details) false false R39.htm 090400 - Disclosure - FIXED ASSETS (Details) Sheet http://raptorpharma.com/role/FixedAssetsDetails FIXED ASSETS (Details) false false R40.htm 090500 - Disclosure - FAIR VALUE MEASUREMENT (Details) Sheet http://raptorpharma.com/role/FairValueMeasurementDetails FAIR VALUE MEASUREMENT (Details) false false R41.htm 090600 - Disclosure - NOTE PAYABLE (Details) Sheet http://raptorpharma.com/role/NotePayableDetails NOTE PAYABLE (Details) false false R42.htm 090700 - Disclosure - ACCRUED LIABILITIES (Details) Sheet http://raptorpharma.com/role/AccruedLiabilitiesDetails ACCRUED LIABILITIES (Details) false false R43.htm 090800 - Disclosure - STOCK OPTION PLANS (Details) Sheet http://raptorpharma.com/role/StockOptionPlansDetails STOCK OPTION PLANS (Details) false false R44.htm 090900 - Disclosure - INCOME TAXES (Details) Sheet http://raptorpharma.com/role/IncomeTaxesDetails INCOME TAXES (Details) false false R45.htm 091000 - Disclosure - ISSUANCE OF COMMON STOCK (Details) Sheet http://raptorpharma.com/role/IssuanceOfCommonStockDetails ISSUANCE OF COMMON STOCK (Details) false false R46.htm 091100 - Disclosure - WARRANTS (Details) Sheet http://raptorpharma.com/role/WarrantsDetails WARRANTS (Details) false false R47.htm 091200 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://raptorpharma.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) false false R48.htm 091300 - Disclosure - QUALIFYING THERAPEUTIC DISCOVERY PROJECT GRANT (Details) Sheet http://raptorpharma.com/role/QualifyingTherapeuticDiscoveryProjectGrantDetails QUALIFYING THERAPEUTIC DISCOVERY PROJECT GRANT (Details) false false R49.htm 091400 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://raptorpharma.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) false false R50.htm 091500 - Disclosure - QUARTERLY RESULTS OF OPERATIONS (UNAUDITED) (Details) Sheet http://raptorpharma.com/role/QuarterlyResultsOfOperationsUnauditedDetails QUARTERLY RESULTS OF OPERATIONS (UNAUDITED) (Details) false false R51.htm 091600 - Disclosure - Schedule II VALUATION AND QUALIFYING ACCOUNTS (Details) Sheet http://raptorpharma.com/role/ScheduleIiValuationAndQualifyingAccountsDetails Schedule II VALUATION AND QUALIFYING ACCOUNTS (Details) false false All Reports Book All Reports Element rptp_AmountOfLoanPerTranche had a mix of decimals attribute values: -6 -5. Element rptp_ChangeInFairValueRecognizedInEarnings had a mix of decimals attribute values: -5 -3. Element rptp_CommonStockIssuedInSpecifiedPeriodAtSpecifiedPriceOnePerSharePursuantToStockPurchaseAgreement had a mix of decimals attribute values: -3 -2. Element rptp_CommonStockIssuedInSpecifiedPeriodAtSpecifiedPriceTwoPerSharePursuantToStockPurchaseAgreement had a mix of decimals attribute values: -3 -2. Element rptp_EffectiveIncomeTaxRateReconciliationNondeductibleForeignLosses had a mix of decimals attribute values: 0 4. Element rptp_EffectiveIncomeTaxRateReconciliationProjectGrantIncome had a mix of decimals attribute values: 0 3. Element rptp_FairValueOfWarrantsIssued had a mix of decimals attribute values: -3 -2. Element rptp_IssuanceOfCommonStockAndWarrantsUnderPrivatePlacementSpecifiedPrice had a mix of decimals attribute values: 2 3. Element rptp_PrivatePlacementSalePricePerUnit had a mix of decimals attribute values: 2 3. Element rptp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledWeightedAverageFairValue had a mix of decimals attribute values: 0 2. Element rptp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageFairValue had a mix of decimals attribute values: 0 2. Element rptp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValue had a mix of decimals attribute values: 0 2. Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights had a mix of decimals attribute values: 2 3. Element us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights had a mix of decimals attribute values: -3 0. Element us-gaap_CommonStockSharesIssued had a mix of decimals attribute values: -3 0. Element us-gaap_DebtInstrumentFaceAmount had a mix of decimals attribute values: -6 -5. Element us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments had a mix of decimals attribute values: 0 4. Element us-gaap_FairValueAssumptionsRiskFreeInterestRate had a mix of decimals attribute values: 2 4. Element us-gaap_FiniteLivedIntangibleAssetsNet had a mix of decimals attribute values: -5 -3. Element us-gaap_ProceedsFromIssuanceOfPrivatePlacement had a mix of decimals attribute values: -6 -3. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate had a mix of decimals attribute values: 0 2. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum had a mix of decimals attribute values: 2 4. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum had a mix of decimals attribute values: 2 3 4. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice had a mix of decimals attribute values: 0 2. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice had a mix of decimals attribute values: 0 2. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue had a mix of decimals attribute values: -5 -2. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber had a mix of decimals attribute values: -4 -3. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice had a mix of decimals attribute values: 1 2. Element us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice had a mix of decimals attribute values: 0 2. Element us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit had a mix of decimals attribute values: 0 2. 'Monetary' elements on report '030000 - Statement - Consolidated Statement of Stockholders' Equity (Deficit)' had a mix of different decimal attribute values. 'Monetary' elements on report '090200 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090300 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090500 - Disclosure - FAIR VALUE MEASUREMENT (Details)' had a mix of different decimal attribute values. 'Shares' elements on report '090800 - Disclosure - STOCK OPTION PLANS (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090800 - Disclosure - STOCK OPTION PLANS (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090900 - Disclosure - INCOME TAXES (Details)' had a mix of different decimal attribute values. 'Shares' elements on report '091000 - Disclosure - ISSUANCE OF COMMON STOCK (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '091000 - Disclosure - ISSUANCE OF COMMON STOCK (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '091200 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '091300 - Disclosure - QUALIFYING THERAPEUTIC DISCOVERY PROJECT GRANT (Details)' had a mix of different decimal attribute values. Process Flow-Through: 010000 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Aug. 31, 2010' Process Flow-Through: Removing column 'Aug. 31, 2009' Process Flow-Through: Removing column 'Aug. 31, 2008' Process Flow-Through: Removing column 'Aug. 31, 2007' Process Flow-Through: Removing column 'Aug. 31, 2006' Process Flow-Through: Removing column 'Sep. 07, 2005' Process Flow-Through: 010100 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 020000 - Statement - Consolidated Statements of Comprehensive Loss Process Flow-Through: Removing column '3 Months Ended Nov. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Aug. 31, 2012' Process Flow-Through: Removing column '3 Months Ended May 31, 2012' Process Flow-Through: Removing column '3 Months Ended Feb. 29, 2012' Process Flow-Through: Removing column '3 Months Ended Nov. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Aug. 31, 2011' Process Flow-Through: Removing column '3 Months Ended May 31, 2011' Process Flow-Through: Removing column '3 Months Ended Feb. 28, 2011' Process Flow-Through: Removing column '3 Months Ended Nov. 30, 2010' Process Flow-Through: Removing column '3 Months Ended Aug. 31, 2010' Process Flow-Through: Removing column '3 Months Ended May 31, 2010' Process Flow-Through: Removing column '3 Months Ended Feb. 28, 2010' Process Flow-Through: Removing column '3 Months Ended Nov. 30, 2009' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2009' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2007' Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2006' Process Flow-Through: 030100 - Statement - Consolidated Statement of Stockholders' Equity (Deficit) (Parenthetical) Process Flow-Through: 040000 - Statement - Consolidated Statements of Cash Flows rptp-20121231.xml rptp-20121231.xsd rptp-20121231_cal.xml rptp-20121231_def.xml rptp-20121231_lab.xml rptp-20121231_pre.xml true true